Brand-name drugs used to treat cardiovascular disease are no better than generics, a new review of available evidence shows.
Yet a number of editorials in medical journals, written by specialists, have urged against substituting the less expensive generics for their designer counterparts.
Generic Heart Drugs as Good as Brand-Name Counterparts
A respiratory virus that doesn’t have a vaccine or a specific treatment regimen is spreading...
The Supreme Court on March 2 backed parents' right to be told if their child changes...
